# Clinuvel Pharmaceuticals Limited (CLVLF)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLVLF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 36.92M | $ 10.44M | $ 12.37M | $ 341.0K | $ 248.92M |
| 2025 | $ 95.02M | $ 36.17M | $ 40.80M | $ 528.5K | $ 240.81M |
| 2024 | $ 90.85M | $ 36.49M | $ 32.23M | $ 879.8K | $ 203.01M |
| 2023 | $ 83.11M | $ 32.47M | $ 38.08M | $ 999.9K | $ 164.63M |
| 2022 | $ 74.63M | $ 23.71M | $ 44.79M | $ 1.26M | $ 125.56M |
| 2021 | $ 57.25M | $ 29.51M | $ 21.97M | $ 1.30M | $ 98.74M |
| 2020 | $ 39.30M | $ 20.09M | $ 16.05M | $ 1.32M | $ 73.67M |
| 2019 | $ 38.29M | $ 22.36M | $ 22.44M | $ 432.5K | $ 57.18M |
| 2018 | $ 31.85M | $ 16.52M | $ 14.52M | $ 0 | $ 39.42M |
| 2017 | $ 21.35M | $ 9.14M | $ 12.54M | $ 0 | $ 25.39M |
| 2016 | $ 8.87M | $ -4.06M | $ -6.68M | $ 0 | $ 17.80M |
| 2015 | $ 4.37M | $ -13.70M | $ -5.98M | $ 0 | $ 11.21M |
| 2014 | $ 3.56M | $ -7.38M | $ -6.42M | $ 0 | $ 15.43M |
| 2013 | $ 2.13M | $ -9.35M | $ -9.51M | $ 0 | $ 13.84M |
| 2012 | $ 1.02M | $ -13.76M | $ -14.12M | $ 0 | $ 13.64M |
| 2011 | $ 1.49M | $ -16.33M | $ -13.68M | $ 0 | $ 16.41M |
| 2010 | $ 0 | $ -17.03M | $ -17.48M | $ 0 | $ 26.43M |
| 2009 | $ 0 | $ -23.38M | $ -16.76M | $ 0 | $ 37.05M |
| 2008 | $ 0 | $ -22.84M | $ -11.53M | $ 0 | $ 51.81M |
| 2007 | $ 460.3K | $ -14.91M | $ -14.00M | $ 0 | $ 65.39M |
| 2006 | $ 1.26M | $ -17.93M | $ -19.59M | $ 0 | $ 13.99M |
| 2005 | $ 213.6K | $ -18.90M | $ -17.73M | $ 0 | $ 7.45M |
| 2004 | $ 0 | $ -13.32M | $ -10.61M | $ 0 | $ 8.85M |
| 2003 | $ 0 | $ -7.12M | $ -133.9K | $ 0 | $ 7.53M |
| 2002 | $ 0 | $ -5.81M | $ -4.74M | $ 0 | $ 10.31M |
| 2001 | $ 0 | $ -2.97M | $ -1.13M | $ 0 | $ 13.45M |
| 2000 | $ 0 | $ 0 | N/A | $ 0 | $ 15.32M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 14.64 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.01 |
| Gross Debt / FCF | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/CLVLF.md)
- [Charts](https://sponda.capital/en/CLVLF/charts.md)
- [Compare](https://sponda.capital/en/CLVLF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.